123 related articles for article (PubMed ID: 116791)
1. Non-parenteral combined afterload and preload reduction therapy in congestive heart failure.
Mehta J; Pepine CJ; Conti CR
Clin Cardiol; 1978 Aug; 1(2):68-73. PubMed ID: 116791
[TBL] [Abstract][Full Text] [Related]
2. Haemodynamic effects of hydrallazine and of hydrallazine plus glyceryl trinitrate paste in heart failure.
Mehta J; Pepine CJ; Conti CR
Br Heart J; 1978 Aug; 40(8):845-50. PubMed ID: 99155
[TBL] [Abstract][Full Text] [Related]
3. Afterload reduction and cardiac performance. Physiologic basis of systemic vasodilators as a new approach in treatment of congestive heart failure.
Mason DT
Am J Med; 1978 Jul; 65(1):106-25. PubMed ID: 99030
[TBL] [Abstract][Full Text] [Related]
4. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure.
Gogia H; Mehra A; Parikh S; Raman M; Ajit-Uppal J; Johnson JV; Elkayam U
J Am Coll Cardiol; 1995 Dec; 26(7):1575-80. PubMed ID: 7594088
[TBL] [Abstract][Full Text] [Related]
5. Comparative hemodynamic effects of chewable isosorbide dinitrate and nitroglycerin in patients with congestive heart failure.
Mikulic E; Franciosa JA; Cohn JN
Circulation; 1975 Sep; 52(3):477-82. PubMed ID: 808359
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure.
Massie B; Chatterjee K; Werner J; Greenberg B; Hart R; Parmley WW
Am J Cardiol; 1977 Nov; 40(5):794-801. PubMed ID: 411364
[TBL] [Abstract][Full Text] [Related]
7. Splanchnic venous pressure-volume relation during experimental acute ischemic heart failure. Differential effects of hydralazine, enalaprilat, and nitroglycerin.
Wang SY; Manyari DE; Scott-Douglas N; Smiseth OA; Smith ER; Tyberg JV
Circulation; 1995 Feb; 91(4):1205-12. PubMed ID: 7850960
[TBL] [Abstract][Full Text] [Related]
8. Comparative haemodynamic effects of intravenous nisoldipine and hydralazine in congestive heart failure.
Haitas B; Meyer TE; Angel ME; Reef E
Br J Clin Pharmacol; 1990 Mar; 29(3):366-8. PubMed ID: 2310661
[TBL] [Abstract][Full Text] [Related]
9. Influence of short-term oral hydralazine therapy on exercise hemodynamics in patients with severe chronic heart failure.
Rubin SA; Chatterjee K; Ports TA; Gelberg HJ; Brundage BH; Parmley WW
Am J Cardiol; 1979 Nov; 44(6):1183-9. PubMed ID: 495513
[TBL] [Abstract][Full Text] [Related]
10. Afterload reduction in the treatment of cardiac failure.
Mason DT
Schweiz Med Wochenschr; 1978 Nov; 108(44):1695-703. PubMed ID: 102028
[TBL] [Abstract][Full Text] [Related]
11. Long-term outpatient vasodilator therapy of congestive heart failure. Consideration of agents at rest and during exercise.
Chatterjee K; Massie B; Rubin S; Gelberg H; Brundage BH; Ports TA
Am J Med; 1978 Jul; 65(1):134-45. PubMed ID: 99031
[TBL] [Abstract][Full Text] [Related]
12. [Use of nitroglycerin in the treatment of congestive heart failure].
Curyło AM
Folia Med Cracov; 1989; 30(1-2):23-9. PubMed ID: 2518363
[TBL] [Abstract][Full Text] [Related]
13. Vasodilators as first-line therapy for congestive heart failure: a comparative hemodynamic study of hydralazine, digoxin, and their combination.
Ribner HS; Zucker MJ; Stasior C; Talentowski D; Stadnicki R; Lesch M
Am Heart J; 1987 Jul; 114(1 Pt 1):91-6. PubMed ID: 3604877
[TBL] [Abstract][Full Text] [Related]
14. Bolus intravenous nitroglycerin predominantly reduces afterload in patients with excessive arterial elastance.
Haber HL; Simek CL; Bergin JD; Sadun A; Gimple LW; Powers ER; Feldman MD
J Am Coll Cardiol; 1993 Jul; 22(1):251-7. PubMed ID: 8509548
[TBL] [Abstract][Full Text] [Related]
15. Contrasting acute effects of vasodilators (nitroglycerin, nitroprusside, and hydralazine) on right ventricular performance in patients with chronic obstructive pulmonary disease and pulmonary hypertension: a combined radionuclide-hemodynamic study.
Brent BN; Berger HJ; Matthay RA; Mahler D; Pytlik L; Zaret BL
Am J Cardiol; 1983 Jun; 51(10):1682-9. PubMed ID: 6407295
[TBL] [Abstract][Full Text] [Related]
16. Specific afterload reduction with parenteral hydralazine following cardiac surgery.
Sladen RN; Rosenthal MH
J Thorac Cardiovasc Surg; 1979 Aug; 78(2):195-202. PubMed ID: 459526
[TBL] [Abstract][Full Text] [Related]
17. Clinical and haemodynamic responses to captopril and hydralazine in chronic congestive heart failure: the importance of preload reduction.
Fitzgerald DJ; O'Callaghan WG; O'Malley K; Horgan J; O'Brien E
Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):217S-222S. PubMed ID: 6753903
[TBL] [Abstract][Full Text] [Related]
18. Comparison of haemodynamic effects of oral prazosin, oral hydralazine, and intravenous nitroprusside in same patients with chronic heart failure.
Mehta J; Iacona M; Pepine CJ; Conti CR
Br Heart J; 1979 Dec; 42(6):664-70. PubMed ID: 534583
[TBL] [Abstract][Full Text] [Related]
19. Myocardial ischemia during vasodilator therapy in a canine model of pulmonary hypertension and coronary insufficiency.
Priebe HJ
Anesthesiology; 1992 May; 76(5):781-91. PubMed ID: 1575347
[TBL] [Abstract][Full Text] [Related]
20. Role of nitrates in congestive heart failure.
Cohn JN
Am J Cardiol; 1987 Nov; 60(15):39H-43H. PubMed ID: 3120564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
